The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of strategic review and new funding

5 Jun 2018 07:00

RNS Number : 2590Q
Imaginatik PLC
05 June 2018
 

05 June 2018

Imaginatik plc

("Imaginatik" or "the Company")

 

Result of strategic review and new funding

Board changes

Appointment of new joint broker

 

Highlights

 

· Termination of sale process; retention of existing business;

· Board and management changes including departure of both Chairman and Chief Executive;

· Resultant immediate £750,000 plus reduction in annual costs;

· £225,000 of new funds raised; and

· Appointment of Peterhouse Capital Limited as joint broker

 

Introduction

 

Imaginatik plc (AIM: IMTK.L), the innovation company, provides an update on the result of the Company's strategic review, new funding and changes to the composition of the Company's board of directors.

 

Further to the Company's announcement on 1 February 2018 and subsequent updates, the directors have explored opportunities to sell the Company. They have held detailed discussions with several interested parties but based on the proposals put forward by potential purchasers, the Board decided that it would be unable to make a positive recommendation to the shareholders. As a result, the Board today confirms that it has closed the formal sale process and terminated all discussions with interested parties. Accordingly, the Company is no longer in an Offer Period as defined in the City Code on Takeovers and Mergers.

 

As announced on 29 May 2018, the directors began a parallel process to seek new funding to enable the Company's business to continue for the immediate future. Further to this announcement, the Company has also looked at ways to reduce the Company's cost base.

 

Strategic Review and New Funding

 

The Company confirms that on 4 June 2018 it secured new funding (the "Funding") to enable an alternative strategy to be implemented with a view to securing the Company's long-term future. As part of the Funding, a cost reduction programme has been agreed, which is expected to reduce costs by more than £750,000 on an annualised basis, when complete. This compares with an adjusted loss after tax of approximately £550,000* incurred by the Company in the financial year ended 31 March 2017. Additionally, improved operational efficiencies are expected to enable the Company to better grow its revenues at marginal incremental cost.

 

The directors note that the Company retains a roster of 38 customers, currently worth annualised revenues of approximately £2.8m. In the last financial year, the Company secured 13 new customers, seven of which are on annual or multi-year contracts consisting of both technology and consulting, adding to the Company's base of recurring revenue.

 

*Net of an exceptional foreign exchange loss of £0.23m

 

Changes to the Board

 

The board has today accepted the resignation with immediate effect of the Company's Chairman, Matt Cooper. Mr Cooper has waived his entitlement to receive payment in lieu of notice. The directors would like to thank Mr Cooper for his significant financial and strategic support to the Company over the past years and the directors wish Mr Cooper well for the future. Chief Executive Officer, Ralph Welborn has left the Company with immediate effect without compensation.

 

New appointments to the board will be announced in due course, alongside the cost reduction and efficiency programme which has been agreed.

 

Financing 

 

£225,000 of new financing has been secured by way of a fundraising undertaken by Peterhouse Capital which involves a combination of a subscription by Matt Cooper, Chairman, of £225,000 by the issue of a new Convertible Loan Note (the "Notes") and the simultaneous sale by Mr Cooper of £225,000 worth of shares at 0.5p per share to new investors introduced by Peterhouse Capital Limited.

 

As a result of Mr Cooper's share sale, he now holds 7,929,475 shares representing approximately 3.54% of the total issued share capital of the Company.

 

The Notes which are interest free and unsecured, are convertible at a price of 0.5p per share. Given that the Company's current par value is 1p, it is the intention of the Company to shortly convene a general meeting of all shareholders to approve, inter alia, a reduction of the par value to allow the full conversion of the Notes.

 

The issue of the Notes (the "Transaction") is deemed to be a related party transaction as Matt Cooper is a substantial shareholder as well as a director of the Company. The independent directors, being Simon Charles and Shawn Taylor, consider, having consulted with its nominated adviser, that the terms of the Transaction are fair and reasonable insofar as its shareholders are concerned.

 

Appointment of new joint broker

 

The Company has appointed Peterhouse Capital Limited as joint broker and thanks them for their contribution in securing the current fund raising.

 

For further information please contact:

 

Imaginatik plc

Tel: +44 (0) 1329 243 243

Shawn Taylor, CFO

finnCap Ltd - Nomad and broker

Tel: +44 (0) 20 7220 0500

Jonny Franklin-Adams/Max Bullen-Smith, corporate finance

Camille Gochez, corporate broking

Peterhouse Capital Limited - Joint broker

Tel: +44 (0) 20 7220 9797

Duncan Vasey / Lucy Williams

Alma PR

Tel: +44 (0) 20 8004 4218

Caroline Forde / Robyn Fisher

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Matthew Cooper

2.

Reason for the Notification

a)

Position/status

Chairman

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Imaginatik plc

b)

LEI

213800ZY2C2TI2C5WQ61

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

 

Ordinary shares of 1p

Identification code

GB00BP8XY588

b)

Nature of the transaction

Sale of Ordinary Shares

c)

Price(s) and volume(s)

Sale of Ordinary Shares

 

Price(s)

Volume(s)

0.005p

45,000,000

d)

Aggregated information:

· Aggregated volume

· Price

n/a

e)

Date of the transaction

04 June 2018

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

About Imaginatik

 

Imaginatik provides a range of Innovation solutions comprised of consultancy, enterprise software and program management to deliver innovation results to companies such as Exxon Mobil, Altria, Shell, Goodyear, the Yorkshire Building Society, Caterpillar, AECOM, Novartis and Cargill. Few companies possess the internal capability to consistently generate fresh ideas, identify those worth pursuing and reliably transform them into real, value-enhancing assets. Imaginatik's mission is to help these companies build sustainable innovation competencies. In 2016 Forrester Research found that "Imaginatik has the most comprehensive innovation management solution," providing excellent industry recognition of Imaginatik's full-service innovation offering, combining both technology and consultancy services.

 

Imaginatik is a public company whose shares are traded on the AIM market of the London Stock Exchange (LSE: IMTK.L) with offices in Boston, MA, and Fareham, UK. For more information visit www.imaginatik.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCKMGGVVDMGRZM
Date   Source Headline
30th Dec 20193:10 pmRNSHalf-year Report
2nd Dec 20197:00 amRNSFinal Results
13th Nov 20197:00 amRNSAppointment of Joint Broker
28th Oct 20193:03 pmRNSDirector Declaration
27th Sep 201911:30 amRNSUpdate, Proposed Transaction and RPT
5th Sep 20194:18 pmRNSDirectorate Change
6th Aug 20197:31 amRNSRe Suspension and Update
6th Aug 20197:30 amRNSSuspension - Abal Group Plc
2nd Aug 20199:49 amRNSUpdate on suspension date
24th Jun 20199:11 amRNSUpdate on Board Changes
3rd May 20192:01 pmRNSHolding(s) in Company
3rd May 20199:00 amRNSPrice Monitoring Extension
2nd May 201911:55 amRNSHolding(s) in Company
1st May 201911:01 amRNSHolding(s) in Company
1st May 201910:58 amRNSHolding(s) in Company
29th Apr 201910:28 amRNSHolding(s) in Company
26th Apr 201911:52 amRNSHolding(s) in Company
5th Apr 20192:22 pmRNSHolding(s) in Company
1st Apr 20198:10 amRNSUpdate on Board changes
1st Mar 20197:00 amRNSUpdate and Directorate Change
5th Feb 201911:48 amRNSHolding(s) in Company
5th Feb 201910:08 amRNSCompletion of disposal
5th Feb 20198:23 amRNSHolding(s) in Company
31st Jan 20195:30 pmRNSImaginatik
31st Jan 201910:09 amRNSHolding(s) in Company
30th Jan 20199:38 amRNSHolding(s) in Company
28th Jan 201910:27 amRNSResult of GM
14th Jan 20197:00 amRNSIssue of Equity
10th Jan 20197:00 amRNSProposed sale of business and assets
13th Dec 20183:42 pmRNSHolding(s) in Company
12th Dec 201812:37 pmRNSResult of AGM
10th Dec 20183:47 pmRNSHolding(s) in Company
4th Dec 20182:10 pmRNSHolding(s) in Company
4th Dec 20189:23 amRNSHolding(s) in Company
3rd Dec 20183:01 pmRNSIssue of Equity
3rd Dec 20187:00 amRNSContract Award
28th Nov 20183:33 pmRNSHolding(s) in Company
28th Nov 20187:00 amRNSHolding(s) in Company
27th Nov 20187:00 amRNSResult of Open Offer
19th Nov 20187:00 amRNSHalf-year Report
16th Nov 20187:00 amRNSNotice of AGM
8th Nov 201812:52 pmRNSDirectorate Change
2nd Nov 20185:29 pmRNSHolding(s) in Company
2nd Nov 20187:00 amRNSOpen Offer
31st Oct 201812:37 pmRNSAdmission of new shares
26th Oct 20187:30 amRNSRestoration - Imaginatik plc
26th Oct 20187:00 amRNSAppointment of NOMAD and Completion of Placing
18th Oct 20187:00 amRNSCompany Update
1st Oct 20187:00 amRNSCompany Update
28th Sep 201811:01 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.